Alkem Labs Senior Management Personnel Adil Billimoria retires
Mumbai: Alkem Labs has announced the retirement of Adil Billimoria, Senior Management Personnel of the Company.
"We wish to inform you that Mr. Adil Billimoria, Senior Management Personnel of the Company shall retire from the Company with effect from the closing of business hours of 31st March, 2025," the Company stated in a BSE filing.
Medical Dialogues team had earlier annnounced the appointment of Shirish Purushotham Ambulgekar and Sanjay Kumar Dipak at a senior management position in the Company.
Read also: Alkem Labs appoints Shirish Purushotham Ambulgekar at senior management position
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, Ophthalmology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
Read also: Alkem Labs appoints Sanjay Kumar Dipak at senior management position
